Empowering your pathology lab to reach its full potential
At Roche, we are personally committed to driving diagnostic certainty for life-changing decisions in pathology. We do this by advancing science to improve patients’ lives, and by delivering innovative solutions that break down the barriers anatomic pathology labs face every day. This empowers our customers to reach their full potential now, and build a future that holds the potential to beat cancer.
Drawing on a deep understanding of anatomic pathology, we deliver a well-integrated, end-to-end solution that advances clinical decision-making in oncology. We keep our customers at the forefront through continuous improvements in staining automation, lab integration, and digitisation while pushing the boundaries of medical science to provide high medical value with the most comprehensive assay portfolio available today.
Committed to eliminating the burden of cancer
At Roche, we believe beating cancer begins in the lab, with the right answer, for the right patient, at the right time. We have a clear vision for a future where people anywhere in the world can harness the power of high-quality, reliable diagnostics that clinicians need to provide the highest standard of care.
This drives our commitment to ongoing innovations that redefine the standard of care and bring us closer to our goal of defeating cancer.
Automated instrumentation for timely, reliable and reproducible results.
Break down lab barriers with connected and integrated instrumentation and software.
Taking labs further on their journey to impact patients' lives with the industry's most robust menu of reliable, ready-to-use assays across a multitude of disease areas.
Driving diagnostic certainty for life-changing decisions in precision oncology with the broadest menu of companion diagnostic tests available today.1
Integrated, open, end-to-end digital pathology and clinical decision solutions to enable better, more personalised healthcare.
Solving tomorrow’s problems, today.
Benefits of pathology lab solutions from Roche
Amplify your impact on patient outcomes with high medical value solutions
Our commitment to high medical value innovation ensures that laboratories benefit from a leading-edge test menu across several disease areas, including the gold standard in breast diagnostics.1 We offer the most comprehensive menu of ready-to-use immunohistochemistry/in situ hybridisation (IHC/ISH) assays, including the most companion diagnostic tests available today2 to link diagnoses with therapeutic options that can lead to better outcomes for patients.
Each of the 200+ assays in our extensive menu is built with clinical utility in mind. We uphold rigorous scientific standards throughout the development process to ensure you have robust and reliable products in your hands to help maximise your impact on patients’ lives.
This dedication to innovation, diversity, and quality underscores our mission to empower healthcare providers with state-of-the-art solutions across our pathology portfolio.
- Over two decades of experience developing predictive diagnostics
- Companion diagnostics that offer access to 17 personalised therapies on label and counting
- An estimated 3.5 million patients tested with our HER2, ALK, and PD-L1 companion diagnostic tests annually*3
Optimise and grow your pathology lab business with solutions built with you in mind
We consistently explore new opportunities to help you break down barriers to success through continuous improvements in staining automation, integrated workflow solutions, digitisation, and AI-based clinical decision support.
We have the clinical expertise, innovation mindset, and customer focus to deliver end-to-end digital solutions that support the laboratory’s workflow, from staining to digital imaging to AI-based clinical decision support that drives diagnostic certainty.
In addition, expert Roche personnel support your educational and technical needs to ensure successful set-up, implementation, day-to-day operations, and troubleshooting of our solutions – so you can enjoy peace of mind and freedom to focus on the high-value tasks that can make a day’s work more rewarding.
Partner with the largest investor in new and sustainable solutions4 that change healthcare standards
As the industry leader in diagnostic research and development, we remain the foremost investor in innovations that positively impact lives and shape the future.4
Renowned for our commitment to developing products that enhance lives while prioritising environmental responsibility, we are also dedicated to assisting laboratories in achieving their sustainability objectives and staying ahead of evolving compliance standards. Roche is proud to stand as one of the world's top three sustainable healthcare companies in the Dow Jones Sustainability Index (DJSI).5
Online pathology education portal: Empower your practice
We support pathologists with resources to stay up-to-date on emerging biomarkers and technologies that are rapidly evolving the field of pathology. Our team has developed a variety of tools to elevate your knowledge and confidence in results. Advance your practice with educational content and interactive training to aid in the interpretation of our assays.
Pathology webinars from industry thought leaders
Engage with Roche and industry experts with our curated series of innovative webinars, hosted on BrightTALK. Presented by Roche Diagnostics, these educational live webinars feature insights from key opinion leaders on the latest and most relevant topics in pathology and precision medicine. Join the ongoing conversation in these rapidly evolving areas of healthcare.
Related health topics
*Estimated number of unique patients tested based on total 2022 sales volume
References
- NordiQC. (2020). Nordic Immunohistochemical Quality Control, HER2 run B30 2020
- Data on file. Roche Diagnostics International Ltd.
- Data on file. Roche Diagnostics International Ltd.
- Fierce Biotech. [Internet; cited 2024 18 Jun]. Available from: https://www.fiercebiotech.com/biotech/top-10-pharma-rd-budgets-2022
- GlobeNewswire. [Internet; cited 2024 18 Jun]. Available from: https://www.globenewswire.com/news-release/2023/12/15/2796818/0/en/Roche-named-among-top-three-most-sustainable-healthcare-companies-in-the-Dow-Jones-Sustainability-Indices.html